Dr. Ivan Gentile was born in Castellammare di Stabia (Naples, Italy) on 15.07.1972. He is married with two children. He obtained a degree in Medicine on 25.07.1996 at "Seconda Università di Napoli" with a grade of 110/110 cum laude. From February 1999 to June 1999 he was guest fellow at the Institute of Pathology in Cologne (Germany). On 24.10.2000, he specialized in Infectious Diseases at the University of Naples "Federico II" with maximum marks (70/70 cum laude). From January 2001 to November 2007 he worked as Medical Doctor at the Department of Infectious Diseases – at University of Naples "Federico II". He is Assistant Professor of Infectious Diseases at University of Naples “Federico II” since academic year 2011/2012. He is author of several papers most of them published on International journals with an overall Impact factor of about 300. Total number of citation is 1305 with a H-index of 23 (source Scopus). Guest Referee for several journals such as: “Lancet Infectious Diseases” (I.F. 19,446), “Gut” (I.F. 10,111), “Cochrane Database of Systematic Reviews” (I.F. 5.785); “Liver International” (I.F. 3,824), “Journal of Infection” (I.F: 4.017); “Drug Design, Development and Therapy” (I.F. 3.486) “Journal of Translational Medicine”, (I.F: 3.459), “Expert Review of Anti-Infective Therapy” (I.F. 3.318); “BMC Infectious Diseases” (I.F. 3.025); “Expert Opinion On Drug Metabolism & Toxicology” (I.F.: 2.944); “Hepatology International” (I.F: 2.642); “World Journal of Gastroenterology”(I.F. 2011: 2.547), etc. He is member of Editorial Board of several journals, such as “Reviews on Recent Clinical Trials”, “Journal of Gastroenterology and Hepatology Research”, “Dataset Papers in Medicine (Hepatology Section)”, “Journal of Molecular & Genetic Medicine”, “Journal of Research and Development”, “International Journal of Aids & Its Research”, “International Journal of Microbiology & Advanced Immunology (IJMAI)”, etc. He acted as a reviewer for the funding of research projects for UK Medical Research Council (MRC). He is member of the Italian Society of Infective and Tropical Diseases (SIMIT), and Italian Group for Study of Cryoglobulin (GISC). He was former member of the Expert panel on Public Health of the European Society for Translational Medicine (EUSTM). In July 2013 he won “Fellowship Program 2013” prize as the principal investigator of the project named “Clinical and pharmacological management of HBV-positive pregnant women” financed with the sum of 25,000 € by Gilead Sciences. In July 2015 he won “Fellowship Program 2015” prize as the principal investigator of the project named “Prospective, observational study on the multidisciplinary management of HCV patients with B cell lymphoproliferative malignancies” financed with the sum of 15,000 € by Gilead Sciences. In June 2016 he won “Fellowship Program 2016” prize as the principal investigator of the project named “A digital-based novel strategy for a better self-consciousness of risk factors and evaluation of epidemiology of chronic viral hepatitis” financed with the sum of 20,000 € by Gilead Sciences.

Ivan Gentile Research Interests are Antibiotic therapy, Prevention and Treatment of multiple drug resistance bacterial infections, Treatment of Spontaneous Bacterial Peritonitis, Autism Spectrum Disorders (inter-relation of genes and environment in etiopathogenesis of the disorders), Viral liver disease (HBV, HCV-related chronic hepatitis), Herpesvirus infections, Portal hypertension, Polymorphisms in interferon response to therapy, Randomized controlled trial.